Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
| dc.contributor.author | Mahesh, R. | |
| dc.date.accessioned | 2023-11-21T06:41:36Z | |
| dc.date.available | 2023-11-21T06:41:36Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | In the last few decades, serotonin type-3 (5-HT3) receptor antagonists have been identified as potential targets for anxiety disorders. In preclinical studies, 5-HT3 antagonists have shown promising antianxiety effects. In this study, a novel 5-HT3 receptor antagonist, QCM-13(N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) was evaluated for anxiolytic-like activity in rodent behavioral test battery. | en_US |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399007/ | |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13204 | |
| dc.language.iso | en | en_US |
| dc.publisher | PMC | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | PMC | en_US |
| dc.subject | Anti-anxiety agent | en_US |
| dc.title | Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: